Hyperbaric Oxygen Therapy Devices Market to Expand at 7.20% CAGR to Reach US$2.98 bn by 2020

HBOT is a technique of delivering pure oxygen (100%) to the tissues under higher atmospheric pressures. Due to its ability to enhance the activities of the white blood cells at the wound site and block the cytotoxic effects of cyanide and carbon monoxide, HBOT is gaining wide acceptance across the globe. It has been studied that HBOT saturates the circulatory system of a patient with oxygen, which results in augmented oxygen delivery to the tissues that produce therapeutic effect in a patient’s body. HBOT is used for various medical indications such as necrotizing soft tissue infections, thermal burn injury, decompression sickness, etc. for which they have an FDA approval, however it has been observed that apart from the approved medical conditions HBOT is also used as a viable treatment for many off-label indications such as brain injuries and cancer. Thus, due to the high preference of hyperbaric oxygen therapy among physicians and patients the market of HBOT devices is expected to grow significantly in the near future, across the regions.

This 86 page report gives readers a comprehensive overview of the Hyperbaric Oxygen Therapy (HBOT) Devices Market. Browse through 9 data tables and 17 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/hbo-therapy-devices.html

On the basis of products, the report divides the global hyperbaric oxygen therapy devices market into monoplace HBOT devices, multiplace HBOT devices, and topical HBOT devices. In 2013, this market was led by monoplace HBOT devices, which generated more than US$900 mn at the time. Monoplace HBOT devices are highly sought after due to their high adoption rates coupled with high availability. Additionally, this segment is expected to show the fastest growth rate in the given forecast period, owing to the ease with which monoplace devices can be obtained and installed.

The report creates segments of the global hyperbaric oxygen therapy devices market, according to applications, as gas embolism, infection treatment, decompression sickness, wound healing, and others. Wound healing was the strongest segment in this market for 2013. The report’s authors say that this segment will continue leading the global hyperbaric oxygen therapy devices market for the given forecast period, as it is expanding at the fastest CAGR of 7.9% within it. This is attributed to the largely positive effects that HBOT can have on those suffering from wounds and injuries linked to diabetes.

The geographical analysis given in the report can be best understood through a segmented view, by dividing the global hyperbaric oxygen therapy devices market into the major parts of Asia Pacific, Europe, North America, and the Rest of the World. North America was the dominant region in 2013, owing to a high adoption of the therapy in wound treatment and other infections. On the other hand, the Asia Pacific region is expected to consistently display the fastest growth rate in this market for the given forecast period, owing to a high population density, a growing prevalence of medical complications of diabetes, and a rapidly developing healthcare infrastructure.

Get accurate market forecast and analysis on the Hyperbaric Oxygen Therapy (HBOT) Devices Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=806

The key players in the global hyperbaric oxygen therapy devices market, as stated in the report, are Hyperbaric SAC, Hearmec Co., Ltd., Haux-Life-Support GmbH, Gulf Coast Hyperbaric, Inc., Fink Engineering Pty Ltd., SOS Medical Group Ltd., IHC Hytech B.V., ETC Biomedical System, OxyHeal Health Group, and Sechrist Industries, Inc.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/